http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008136854-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
| filingDate | 2007-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008136854-A |
| titleOfInvention | DIGYDRODIAZEPINES WHICH CAN BE USED AS PROTEINKINASE INHIBITORS |
| abstract | 1. The compound of formula I:! ! where! X1 is a bond, O, NR8, S, SO or SO2; ! Y1 is O or NR9; ! R1 is H, a C1-10 aliphatic fragment, a C3-10 cycloaliphatic fragment, a C6-10 aryl, a 5-10 membered heteroaryl or a 3-10 membered heterocyclyl, wherein said R1 is optionally substituted with 0-5 J1; with the proviso that if X1 is a bond, R1 is not H; ! R2 is H, a C1-10 aliphatic fragment, - (a C1-10 aliphatic fragment) - (a C3-10 cycloaliphatic fragment), a C3-8 cycloaliphatic fragment, a halogen C1-4 aliphatic fragment, wherein said R2 is optionally substituted with 0-4 J2; ! each of R3, R4, R5 and R6 independently represents H, C1-10 aliphatic fragment, C3-10 cycloaliphatic fragment, C6-10aryl or 5-10 membered heteroaryl, where each R3, R4, R5 and R6 is optionally and independently substituted with 0-5 J3, J4, J5 and J6, respectively; and! R7 is H, C (O) R, C (O) OR or C (O) NRR ', a C1-10 aliphatic fragment, a C3-10 cycloaliphatic fragment, C6-10aryl, 5-10 membered heteroaryl, 3-10 membered heterocyclyl , - (C1-6 aliphatic fragment) - (C3-10 cycloaliphatic fragment), - (C1-6 aliphatic fragment) - (C6-10 aryl), or - (C1-6 aliphatic fragment) - (5-10 membered heteroaryl), or - (C1-6 aliphatic fragment) - (3-6 membered heterocyclyl); wherein said R7 is optionally substituted with 0-5 J7; or ! R3 and R4, together with the carbon atom to which they are attached, optionally form a 3-8 membered saturated or partially unsaturated monocyclic fragment containing 0-4 heteroatoms independently selected from O, N and S; wherein said monocyclic fragment formed by R3 and R4 is optionally substituted with 0-4 J34; ! R5 and R6, together with the carbon atom to which they are attached, optionally form a 3-8 membered saturated or partially unsaturated monocyclic |
| priorityDate | 2006-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.